Jun 26, 2026 09:31AM
Jun 17, 2026 11:56AM
Jun 4, 2026 04:39PM
Jun 3, 2026 03:11AM
May 29, 2026 12:28PM
May 22, 2026 12:13PM
May 22, 2026 07:00AM Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
May 18, 2026 02:05PM
May 13, 2026 02:11PM
May 13, 2026 02:11PM
May 5, 2026 12:42PM
May 5, 2026 12:41PM
Apr 22, 2026 11:22AM
Apr 10, 2026 01:03PM Lupin Launches Dapagliflozin Tablets in the United States
Apr 8, 2026 10:06AM
Apr 7, 2026 02:33PM
Mar 31, 2026 09:11AM
Mar 25, 2026 08:29AM
Feb 26, 2026 10:57AM
Feb 24, 2026 01:09PM
Feb 4, 2026 12:51PM Lupin Launches Topiramate Extended-Release Capsules in the United States
Feb 2, 2026 08:30AM
Nov 14, 2025 07:00AM
Oct 9, 2025 05:58AM
Oct 9, 2025 05:58AM
Sep 10, 2025 08:43AM
Sep 10, 2025 08:43AM
Jul 15, 2024 07:20AM Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC
Aug 16, 2023 01:15PM
Jul 29, 2023 11:06AM
Dec 21, 2022 12:17PM
Feb 17, 2022 08:45AM
Jan 27, 2022 10:17AM
Oct 14, 2021 07:34AM
Jul 1, 2021 08:00AM Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSEC® (secnidazole) for the Treatment of Trichomoniasis
Feb 1, 2021 06:47AM
Nov 16, 2020 01:01AM
Aug 14, 2020 08:12AM
Jul 8, 2020 12:21AM
Jun 11, 2020 12:54AM
Jun 9, 2020 08:38AM
May 4, 2020 07:30AM Lupin Announces Positive Topline Results From its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis
Apr 22, 2020 07:23AM
May 29, 2018 01:32PM
Oct 11, 2017 07:10AM

326,430 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All